Dr. Dooley is a Professor of Medicine and Director of the Division of Infectious Diseases at Vanderbilt University Medical Center. She received her medical training at Duke University, earned an MPH at the University of North Carolina in Chapel Hill, and completed internal medicine residency and fellowships in clinical pharmacology and infectious diseases at Johns Hopkins University School of Medicine, earning at PhD at the School of Public Health along the way. Her research focuses on tuberculosis therapeutics with an emphasis on clinical trials of TB drugs and HIV/TB co-treatment, as well as clinical pharmacology of TB and HIV drugs. She is lead investigator for trials of therapeutics for drug-sensitive and drug-resistant TB, TB-HIV, and pediatric TB meningitis. She is on the TB scientific committees of the AIDS Clinical Trials Group and IMPAACT networks and is a consultant to World Health Organization on TB therapeutics and pharmacology. She maintains an active HIV clinical practice.
Kelly E. Dooley, MD, PhD, MPH